Moderators: dndodd , Honeycomb777 , SPORT19 , livendi , ShortsRClowns
Search This Board: 
Created: 10/18/2010 05:37:11 PM - Followers: 503 - Board type: Free - Posts Today: 0


Titan Medical

January 10, 2022 Titan Medical Corporate Presentation

*200+ patents issued or pending


Surgeon Feedback From Initial Clinical Testing:

Ricardo Estape, M.D., a robotic gynecologic oncology surgeon from South Miami Gynecology Oncology Group who specializes in robotic single port surgeries, said, “The SPORT Surgical System performed beyond my expectations and I was able to complete a variety of critical surgical tasks with the necessary dexterity and precision through a single incision. The robotic instruments provided the necessary articulation, range of motion and rigidity along with 3D high-definition video on the flat panel monitor that allowed me to complete the surgery in a comfortable posture. This could be a game changer in gynecological surgery.”  SEE VIDEO

Eduardo Parra-Davila, M.D., a robotic colorectal surgeon at Florida Hospital who has trained thousands of surgeons worldwide on robotic surgery, commented, “Single port surgery without robotic assistance is not easy and yet it remains highly beneficial because of the desire to have fewer ports. It’s all about robotic articulation delivered through a single incision that allows for the reach, necessary angles and multi-quadrant access to treat diseases in colorectal surgeries. The SPORT Surgical System has the promise to become a valuable tool for all robotic surgeons looking to do single port surgery in the future.”    SEE VIDEO

Arnold Advincula, M.D., Chief of Gynecologic Specialty Surgery at Columbia University and an expert in robotic surgery, said, “After using the SPORT system, I am more convinced that single-port robotic surgery could become a reality for many patients. Previous approaches to single-incision surgery have been limiting and ineffective. The SPORT system demonstrated that it can not only address those limitations, but it may also provide some unique capabilities for enabling a variety of gynecologic surgeries through a single incision. The future of single-port robotic surgery is bright and I am excited to actively participate in this journey with Titan Medical.”

Vipul Patel, M.D., a world-renowned robotic urology surgeon from the Global Robotics Institute at Florida Hospital and the only surgeon in the world to have completed 10,000 robotic prostatectomies, said, “Although multi-port robotic prostatectomy is currently the standard of care in urology, single port robotic surgery could be the next frontier in urology and other surgical disciplines. It was exciting for me to use Titan Medical’s SPORT system at Florida Hospital Nicholson Center. The technological capabilities of the SPORT system are very encouraging and the early success in establishing feasibility is an important step in the right direction.”

William Burke, M.D., a gynecologic oncologist at Stony Brook University Hospital with extensive robotic surgery experience, commented, “Having completed thousands of multi-port robotic surgeries over several years of practice, I was pleased with the capabilities of the SPORT system that eased my transition from a multi-port approach to single-port robotic surgery. The workspace, access and ease of use while maintaining critical multi-port robotic features such as multi-articulated instruments and high-definition 3D visualization through a single incision, are important factors in transitioning from multi-port to single-port robotic surgery. I must say that the SPORT system, with its sophistication, makes a highly compelling case for single-port robotic surgery.”

Lee Swanstrom, MD, FACS, Chief Innovation Officer of IHU Strasbourg, said, “I was pleased with my first experience with the SPORT system for applications in abdominal procedures. There are many patients undergoing general surgical procedures who could greatly benefit from a reduced number of incisions. Single-port robotic surgery can be a truly enabling solution for patients and surgeons alike, and it is exciting to see that the SPORT system takes us much closer to that possibility.”

Jelle Ruurda, MD, a gastrointestinal and oncologic surgeon at University Medical Center Utrecht, who has several years of robotic surgery experience, commented, “Many oncologic general surgery procedures require specimen retrieval at the end of the procedure. These procedures are natural applications for single-port robotic surgery. My first operation of the SPORT system in a preclinical environment was very exciting, and the system shows great promise for future clinical use. I look forward to the opportunity to work together with Titan Medical to evolve a single-port robotic surgery option for my oncology patients. Based on this first experience, I am confident that single-port robotic surgery has a bright future”.

Eric Barret, MD, a world-renowned robotic urologic surgeon at Institut Mutualiste Montsouris, said, “Having performed many single-incision robotic surgeries with flexible, non-wristed and crossed-over instruments, my first experience with the SPORT system was exceptional. The SPORT system addresses many limitations of previous laparoscopic and robotic single-incision surgery approaches, and holds significant promise for meaningful use in urologic applications.”


SPORT™ Surgical System

A robotic system like no other!

The SPORT Surgical System is a versatile single incision advanced robotic surgical system that features state-of the-art multi-articulated instruments with single-use replaceable tips, 3D high definition visualization on a flat-screen monitor, ergonomic open workstation and a single-arm mobile patient cart for ease of set up while enabling broad applications of single and multi-quadrant surgeries previously not possible with current robotic solutions.

Titan Medical Inc. is a Canadian public company, headquartered in Toronto, Ontario, that trades on the Toronto Stock Exchange (TMD) and the OTCQX in the United States (TITXF). Titan is developing the SPORT™ (Single Port Orifice Robotic Technology) Surgical System for use in minimally invasive surgery (“MIS”) that is expected to be commercially available in 2019. Titan’s robotic surgical system is being designed to expand robotic surgery into areas that are currently underserviced. This will allow surgeons to perform procedures within small to medium size surgical spaces such as general surgery and cholecystectomy. Currently, the most common medical procedures for which robotic systems are used are hysterectomies and prostatectomies. Titan plans to expand the scope and obtain approval for various surgical procedures as outlined in their Corporate Presentation.

The SPORT™ Surgical System includes the following:
* a single-port surgeon controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and * a surgeon workstation that provides the surgeon with an interface to the robotic platform   for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient’s body during MIS procedures.

Paul Cataford

Interim President & CEO


Prior to assuming the role of Interim President & CEO, Mr. Cataford was the CEO and co-founder of Zephyr Sleep Technologies Inc., a private medical device company specializing in the treatment and diagnoses of sleep-disordered breathing.

In his over 10 years at Zephyr, Mr. Cataford was able to grow the team to over 65 people, clear class II medical devices through both 510 (k) and De Novo FDA approval paths and build a 13485: 2016 certified manufacturing facility.  Zephyr successfully closed on two joint ventures with established dental technology companies raising over $20 million from a combination of strategic and private investors.  He brings significant high technology and medical device company experience and is a key contributor to strategy, M&A, corporate finance, governance, team building and empowerment and scale. Over the last 25 years, Mr. Cataford has also served as independent corporate director on a number of TSX, TSXV and NASDAQ company boards including: Sierra Wireless, Inc., Trakopolis IoT Corp., SemiBioSys Genetics Inc., and AGJunction Inc. Mr. Cataford has a Bachelor of Science degree in Mechanical Engineering from Queen’s University, an MBA specializing in Finance and International Strategy from Schulich School of Business at York University, and is a graduate of the Institute of Corporate Directors – Directors College, Rotman School of Business at the University of Toronto. 


                                                                                  Surgeon Advisory Board

Arnold Advincula, MD

Dr. Advincula is Vice-Chair of Women’s Health & Chief of Gynecology at the Sloane Hospital for Women, Columbia University Medical Center/New York Presbyterian Hospital. Formerly, he was Professor of Obstetrics and Gynecology, Director of the Minimally Invasive Surgery Division and Fellowship, and Director of the Endometriosis Center at the University of Michigan. More recently, he was Director of the Center for Specialized Gynecology and Director of the Education Institute at the Nicholson Center, an advanced medical and surgical simulation training facility at Florida Health. He is currently Vice President of the American Association of Gynecologic Laparoscopy and a Member-at-Large for the Society of Gynecologic Surgeons. He is a leader in minimally invasive surgical techniques and one of the world’s most experienced gynecologic robotic surgeons, who has published and taught extensively in the area of minimally invasive surgery, as well as developed surgical instruments that are in use worldwide.

Juliane Bingener-Casey, MD

Dr. Juliane Bingener is Professor of Surgery, Mayo Clinic College of Medicine, and Vice Chair for Quality, Safety and Service in the Mayo Clinic Department of Surgery. She has a joint appointment in the Division of Gastroenterology and Hepatology, which supports her clinical interests in minimally invasive surgery, endoscopy, and gastrointestinal disease. Her research focuses on patient reported outcomes and novel technology in the diagnosis and treatment of these diseases. Dr. Bingener’s previous work included the development of a Natural Orifice Translumenal Endoscopic Surgery (NOTES) technique for using an omental patch to close perforated ulcers. Her ongoing interests focus on the development, study, and implementation of innovative endoscopic and laparoscopic approaches for gastrointestinal diseases.

W. Douglas Boyd, MD

Dr. Boyd is a Professor of Surgery and Director of Robotics and Biosurgery at the University of California Davis. He is Head of Adult Cardiac Surgery and Surgical Director of the Transcatheter Valve Program. He is recognized for his pioneering work in cardiothoracic surgery and for his use of robotic-assisted surgical systems. He specializes in minimally invasive cardiac and robotic-assisted heart surgery. Dr. Boyd completed the world’s first closed-chest, beating-heart coronary artery bypass surgery using a robotic system in 1999. Prior to his appointment as a professor of surgery at UC Davis Health System, Dr. Boyd served as chair of the Department of Cardiothoracic Surgery at the Cleveland Clinic in Florida. As the author of more than 70 peer-reviewed, journal articles, Dr. Boyd’s research interests include cardiac tissue regeneration using extracellular matrix/stem cells, new techniques for robot-assisted minimally invasive coronary artery revascularization, valve surgery and tele-surgery. He is a graduate of Carleton University in Ottawa, Canada and obtained his medical degree from the University of Ottawa, Canada.

Demetrius EM Litwin, MD, MBA, FRCS, FACS, FICS

Dr. Litwin trained in General Surgery at the University of Saskatchewan, and completed a hepatobiliary fellowship at the University of Toronto. He was an early pioneer in laparoscopic surgery, having performed the first laparoscopic cholecystectomy in Western Canada in 1990 and the first laparoscopic colectomy in Canada in 1991. He was a leader in educating a large number of surgeons across Canada in basic and advanced laparoscopic techniques. During the early advent of minimally invasive surgery, he innovated new laparoscopic approaches to the spine and aorta, and he participated in the development of HandPortTM, a hand assist device for laparoscopic surgery. In 1993, Dr. Litwin became the Director of Minimally Invasive Surgery at the University of Toronto. In 1997, he moved to the University of Massachusetts as Chief of Minimally Invasive Surgery. Since 2004, he has been Chairman of Surgery at the University of Massachusetts Medical School and UMass Memorial Medical Center, one of the largest Academic Health Sciences Centers in Massachusetts. There, he continues to practice minimally invasive surgery of the abdomen in addition to his administrative role.

Lee L Swanstrom, MD, FACS

Dr. Swanstrom heads the Division of GI and Minimally Invasive Surgery at the Oregon Clinic and is Director of the Providence Health System’s Complex GI and Foregut Surgery Postgraduate Fellowship Program. In addition, he is Clinical Professor in the Department of Surgery at OHSU, a Director of the American Board of Surgery, and Past President of both the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) and the Fellowship Council (FC). Most recently, he became the Chief Innovations Officer and Director of the Innovations Fellowship at the Institutes des Hôpitalo Universitaires of the University of Strasbourg, France. He is the editor of Surgical Innovation and the author of over 300 scientific papers and 50 book chapters. This has resulted in 13 patents and a successful medical device startup company. He is and has been an investigator on numerous outcomes research studies for new procedures such as Natural Orifice Translumenal Endoscopic Surgery (NOTES) to determine their safety and efficacy for establishing new standards of care. He remains focused on developing innovative approaches to the minimally invasive treatment of foregut and other gastrointestinal disorders.

John Valvo, MD

Dr. Valvo, a practicing surgeon, is the Executive Director of Robotic and Minimally Invasive Surgery at Rochester General Hospital in Rochester, New York, where he formerly was the Chief of Urology. Following a 20-year career performing open surgery, Dr. Valvo founded the robotic surgery program at Rochester General Hospital in early 2004, which currently ranks in the top two percent of robotic surgery volume in the United States. The program has trained over 30 robotic surgeons and enabled the completion of more than 7,000 robotic urology, gynecology, general and colorectal surgeries to date. Dr. Valvo has authored more than 100 scientific articles and helped start many robotic programs in the northeast. His focus on robotic surgery credentialing led to a notable published paper on policy guidelines for robotic surgery. He is a fellow of the American College of Surgeons and American Urological Association, and a member of the Society for Laparoscopic Surgeons. 



Titan's leader


  Patent #                                                    Title of Invention
1 8,930,027   Force Feedback System
2 8,792,688   Methods, systems and devices for three dimensional input and control methods and systems based thereon
3 8,768,509   Snaking robotic arm with movable shapers
4 8,347,754   Multi articulating robotic instrument
5 8,332,072   Robotic hand controller
6 8,306,656   Method and system for performing medical procedure
7 8,224,485   Snaking robotic arm with movable shapers
8 5,853,394   Catheter
9 5,607,407   Catheter assembly
10 4,785,868   Medical needle and method for making
  PUB. APP. NO.  Title

PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
When it comes to TMDI I've been rolling ShortsRClowns 05/03/2022 07:00:12 PM
The mistake for so many on this board Geo2014 11/12/2021 05:10:51 PM
Copied from my InvestorVillage post... 66Mustang 12/30/2020 06:43:29 PM
Two words to say to past execs who Honeycomb777 08/18/2022 10:50:21 PM
Worst yet they will have to share all Adrock 08/18/2022 05:01:53 PM
Folks watch for misinformation about TMDI SPORT19 08/18/2022 03:52:24 PM
Where are you getting the the idea Medtronic SPORT19 08/18/2022 03:51:31 PM
Please explain why Medtronic will buy Titan.. makes SPORT19 08/18/2022 03:50:02 PM
More patents continue. Burn rate continues. Titan has OR Nurse 08/18/2022 03:30:09 PM
No extension this time around….. Delisting or RS likely Tic toc SPORT19 08/17/2022 10:25:26 AM
So, just to be clear here...(this is astounding) Honeycomb777 08/16/2022 11:03:20 AM
Cracks me up...PERFECTIONISM...until BANKRUPTCY or FIRESALE !!! Honeycomb777 08/16/2022 10:01:52 AM
Should see a 400% rise from here - MagnusProfitis 08/16/2022 08:42:34 AM
BOOM! Frankestin 08/16/2022 05:17:59 AM
Add to that a likely RS or delisting….. Good SPORT19 08/12/2022 06:09:25 PM
Robbie, you make a compelling argument. This Katalyst89 08/12/2022 05:58:41 PM
Benchmark bots delayed until "later this year" RobLowe3MD_TN 08/12/2022 07:56:13 AM
.50 SPORT19 08/11/2022 02:43:22 PM
So who thinks that there will be a jmgreeny 08/11/2022 12:11:21 PM
So Scooopers!!!!! MagnusProfitis 08/11/2022 09:49:39 AM
Hi everyone! Don’t throw your pooper scooper away Slick Mic 08/09/2022 05:57:21 PM
No price update today from the peanut gallery?? MX77 08/09/2022 05:14:41 PM
I said SCOOOOOOOOOOOOPem!!! Adrock 08/09/2022 04:39:30 PM
News is going to be out soon and Titan = Retirement 08/09/2022 03:46:02 PM
No - after the 1-30 reverse (June 2018) Honeycomb777 08/04/2022 02:40:48 PM
Maybe you weren’t around…company already did a 1-30 SPORT19 08/03/2022 03:48:10 PM
Huh? SPORT19 08/03/2022 03:46:33 PM
Your math is wrong. If he had 30000 jmgreeny 08/03/2022 01:44:59 PM
ScooooooooooooooopEM!!!!!!!!!! Adrock 08/03/2022 12:43:59 PM
RBOT steadily moving up…. SPORT19 08/02/2022 05:33:48 PM
So u tellin me that an investor that Honeycomb777 08/02/2022 04:17:20 PM
Better hope for delisting ONLY. BelizeMe BelizeMe 08/02/2022 12:46:38 PM
How long before the delisting or another R/S? DRG1025 08/02/2022 10:01:24 AM
Let’s Go Frankenstein Let’s GOooooooooo TIT. Scooooooooooop https://pdfaiw.uspt pontiacg6 07/29/2022 03:55:54 PM
sinister signals Frankestin 07/29/2022 02:24:09 PM
Good luck to us all. My job is ShortsRClowns 07/29/2022 01:56:00 PM
SCOOOOOOOOOOOOP US!!!!! ADD ADD ADDROCK!!!! Adrock 07/28/2022 08:45:57 AM
Yes more news coming our way Titan = Retirement 07/27/2022 09:31:21 PM
.61 AH Adrock 07/27/2022 09:10:58 PM
$75M needed easy and that's after their "pal" Honeycomb777 07/27/2022 09:58:00 AM
Haptic Feedback Scooooooooop!!!! Say what!!!! Is this Breaking News??? No pontiacg6 07/26/2022 10:45:46 PM
Gonna need that excavator sized scoop for the RobLowe3MD_TN 07/26/2022 10:37:18 PM
At .55 Cents? Dam right it’s scoooooooooop time! End of Adrock 07/26/2022 03:01:01 PM
We are still promoting scooping? Lol wow devicerep888 07/26/2022 02:11:52 PM
OH ITS BIG TIME SCOOOOOOOOPING TIME!! This is going Adrock 07/26/2022 01:28:05 PM
He in Park City recreating...after he gave away Honeycomb777 07/25/2022 11:53:25 AM
I can't imagine it either, because it already happened! RobLowe3MD_TN 07/25/2022 11:17:12 AM
Me neither...between 41 and 43 cents per ! Honeycomb777 07/25/2022 11:03:59 AM
This is more good news for a potential acquisition: Adrock 07/25/2022 09:10:06 AM
Agreed. Adrock 07/25/2022 09:09:08 AM
I just can't imagine MDT not buying Titan OR Nurse 07/25/2022 09:01:19 AM
FRED MOLL OR GEOFF MARTHA ??? JNJ/TMDI/MDT????? Vance seems pontiacg6 07/22/2022 06:19:15 PM
BUY OUT COMIN FRANKENSTEIN- LETS goooooooooooooo Vance SCOOOP CITY pontiacg6 07/21/2022 08:58:19 PM
Post Subject